A Novel Function for Programmed Death Ligand-1 Regulation of Angiogenesis

被引:45
|
作者
Jin, Yiping [1 ]
Chauhan, Sunil K. [1 ]
Annan, Jaafar E. I. [1 ]
Sage, Peter T. [2 ]
Sharpe, Arlene H. [2 ]
Dana, Reza [1 ]
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 2011年 / 178卷 / 04期
基金
美国国家卫生研究院;
关键词
ORTHOTOPIC CORNEAL ALLOGRAFTS; ANTIGEN-PRESENTING CELLS; ENDOTHELIAL-CELLS; IMMUNE PRIVILEGE; B7; FAMILY; T-CELLS; EXPRESSION; PD-L1; NEOVASCULARIZATION; B7-H1;
D O I
10.1016/j.ajpath.2010.12.027
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Programmed death ligand-1 (PD-L1) plays a critical role in T-cell regulatory function. Here, we report a newly discovered effect of PD-L1 on angiogenesis. We demonstrate that PD-L1 and its receptor CD80, but not PD-1, are expressed by primary murine lung and heart vascular endothelial cells and the miscrovascular endothelial cell line (Ms1) at both the mRNA and protein levels in vitro. The inhibition of PD-L1 or CD80 expression in MS1 cells, by small-interfering RNA transfection, led to a significant up-regulation of vascular endothelial growth factor receptor 2 expression and cell proliferation levels in MS1 cells. Furthermore, MS1 cells were found to have a significantly lower proliferation and vascular endothelial growth factor receptor 2 expression levels when they were co-cultured with PD-L1-expressing normal corneal epithelial cells, as compared to MS1 cells co-cultured with PD-L1(-/-) corneal epithelial cells. In a suture-induced corneal angiogenesis model, we observed a significantly higher level of angiogenic response in PD-L1(-/-) knockout mice as compared to wild-type mice, although there was no significant difference in the expression of inflammatory cytokines (interleukin-1 alpha, interleukin-1 beta, or tumor necrosis factor-alpha) or the infiltration of innate immune cells (neutrophils and macrophages) between the two groups. We conclude that the expression of PD-L1 in both vascular endothelial cells and corneal epithelial cells regulates corneal angiogenesis. (Am J Pathol 2011, 178:1922-1929; DOI: 10.1016/j.ajpath.2010.12.027)
引用
收藏
页码:1922 / 1929
页数:8
相关论文
共 50 条
  • [1] A Novel Function for Programmed Death Ligand-1: Regulation of Angiogenesis (vol 178, pg 1922, 2011)
    El Annan, Jaafar
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (03): : 1324 - 1324
  • [2] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
    Yu Wei-Bo
    Rao Jian-Yu
    [J]. 慢性疾病与转化医学(英文), 2019, 5 (03) : 170 - 177
  • [3] Optimization of cancer immunotherapy on the basis of programmed death ligand-1 distribution and function
    Zou, Wei
    Luo, Xin
    Gao, Mengyuan
    Yu, Chang
    Wan, Xueting
    Yu, Suyun
    Wu, Yuanyuan
    Wang, Aiyun
    Fenical, William
    Wei, Zhonghong
    Zhao, Yang
    Lu, Yin
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (02) : 257 - 272
  • [4] Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma
    Guo, Jhe-Cyuan
    Tsai, Yu-Chieh
    Pu, Yeong-Shiau
    [J]. UROLOGICAL SCIENCE, 2019, 30 (01) : 2 - 7
  • [5] Programmed Death Ligand-1 Immunohistochemistry Friend or Foe?
    Kerr, Keith M.
    Hirsch, Fred R.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (04) : 326 - 331
  • [6] OCULAR ADVERSE EVENTS ASSOCIATED WITH PROGRAMMED DEATH-1 AND PROGRAMMED DEATH LIGAND-1 IMMUNOTHERAPY
    Young, LeAnne
    Finnigan, Shanda
    Streicher, Howard
    Chen, Helen
    Murray, James
    Sen, H. Nida
    Sharon, Elad
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A386 - A387
  • [7] Expression of programmed death ligand-1 and programmed death 1 in hepatocellular carcinoma and its clinical significance
    Long, J.
    Qu, Tao
    Pan, X. F.
    Tang, X.
    Wan, H. H.
    Qiu, P.
    Xu, Yan-Hua
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S1188 - S1192
  • [8] Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
    Banerjee, Debasree
    Monaghan, Sean
    Zhao, Runping
    Walsh, Thomas
    Palmisciano, Amy
    Phillips, Gary S.
    Opal, Steven
    Levy, Mitchell M.
    [J]. CRITICAL CARE, 2018, 22
  • [9] Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
    Debasree Banerjee
    Sean Monaghan
    Runping Zhao
    Thomas Walsh
    Amy Palmisciano
    Gary S. Phillips
    Steven Opal
    Mitchell M. Levy
    [J]. Critical Care, 22
  • [10] Inhibition of Programmed Death Receptor-1/Programmed Death Ligand-1 Interactions by Ginsenoside Metabolites
    Yim, Nam-Hui
    Kim, Young Soo
    Chung, Hwan-Suck
    [J]. MOLECULES, 2020, 25 (09):